Ali Gharibi Loron

Dr. Ali Gharibi Loron

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2017 in The Korean Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
PDF file
MHMohammad Ali Hosseinian
Mohammad Ali Hosseinian
ALAli Gharibi Loron
Ali Gharibi Loron
YSYalda Soleimanifard
Yalda Soleimanifard
Mohammad Ali Hosseinian, M.D., Ali Gharibi Loron, M.D., Yalda Soleimanifard, M.D.. Korean J Thorac Cardiovasc Surg 2017;50:36-40. https://doi.org/10.5090/kjtcs.2017.50.1.36

7 September 2015 in European Journal of Orthopaedic Surgery & Traumatology
Verified
Journal Article
Closed access
PDF file
MHMohammad Ali Hosseinian
Mohammad Ali Hosseinian
ALAli Gharibi Loron
Ali Gharibi Loron
BNBehzad Nemati
Behzad Nemati
MKMohsen Khandaghy
Mohsen Khandaghy

Verified
Journal Article
Open access
PDF file
AAAbudumijiti Aibaidula
Abudumijiti Aibaidula
ALAli Gharibi Loron
Ali Gharibi Loron
SBSamantha M. Bouchal
Samantha M. Bouchal
MBMegan M. J. Bauman
Megan M. J. Bauman
HYHyo Bin You
Hyo Bin You
IPIan F. Parney
Ian F. Parney
Glioblastoma (GBM), the most common primary malignant brain tumor in adults, has a median survival of 14–15 months despite aggressive treatment. Monitoring relies on MRI, but differentiating tumor progression from pseudo-progression or radiation necrosis remains difficult. Plasma extracellular vesicles (EVs) are emerging as promising non-invasive biomarkers due to their molecular cargos and accessibility. This review evaluates studies that specifically isolated plasma EVs for molecular profiling in GBM diagnosis and monitoring. Biomarkers (miRNA, RNA, DNA, proteins), EV characterization methods, and advancements in enriching tumor-derived EV subpopulations and assessing their diagnostic and prognostic potential are highlighted. Plasma EVs carry diverse cargos, including miRNAs (e.g., miR-21, miR-15b-3p), mRNAs (e.g., EGFRvIII), circRNAs, and proteins (e.g., CD44, GFAP). Composite molecular signatures have achieved sensitivities of 87–100% and specificities of 73–100% for GBM diagnosis. Tumor-derived EVs, enriched using techniques like SEC-CD44 immunoprecipitation, microfluidic platforms, or 5-ALA-induced PpIX fluorescence, enhance biomarker detection. Non-tumor-derived EVs may also reflect GBM’s systemic effects. Challenges include EV heterogeneity, non-EV contamination, and variable biomarker expression across studies. Plasma-EV-based liquid biopsies offer significant potential for GBM monitoring, with advanced enrichment methods improving tumor-specific biomarker detection. Standardizing isolation protocols and validating biomarkers in larger cohorts are critical for clinical translation.

1 January 2017 in Iranian Biomedical Journal
Verified
Journal Article
Open access
PDF file
ALAli Gharibi Loron
Ali Gharibi Loron
SSSoroush Sardari
Soroush Sardari
JNJamshid Narenjkar
Jamshid Narenjkar
MSMohammad Sayyah
Mohammad Sayyah
The Iranian Biomedical Journal (ISSN 1028-852X) is an international quarterly publication of the Pasteur Institute of Iran.

10 February 2018 in Microsurgery
Verified
Journal Article
Closed access
PDF file
MHMohammad Ali Hosseinian
Mohammad Ali Hosseinian
ALAli Gharibi Loron
Ali Gharibi Loron
BHBehzad Nemati Honar
Behzad Nemati Honar

29 April 2017 in European Journal of Plastic Surgery
Verified
Journal Article
Closed access
PDF file
MHMohammad Ali Hosseinian
Mohammad Ali Hosseinian
SSSadegh Shirian
Sadegh Shirian
ALAli Gharibi Loron
Ali Gharibi Loron
AEAbdul Ali Ebrahimy
Abdul Ali Ebrahimy
GHGholam Hossein Hayatolah
Gholam Hossein Hayatolah